Reflect Scientific, Inc.
RSCF
$0.0397
-$0.0003-0.75%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 25.64% | 57.94% | -17.07% | -47.08% | -42.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.64% | 57.94% | -17.07% | -47.08% | -42.70% |
| Cost of Revenue | 11.18% | 27.27% | -20.56% | -41.15% | -21.08% |
| Gross Profit | 38.46% | 91.06% | -14.09% | -51.08% | -53.88% |
| SG&A Expenses | 4.44% | 4.90% | 0.23% | -2.03% | 0.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.23% | 11.93% | -9.22% | -20.69% | -10.65% |
| Operating Income | 79.74% | 84.53% | -36.26% | -618.65% | -160.35% |
| Income Before Tax | 90.32% | 89.85% | -29.79% | -609.10% | -159.30% |
| Income Tax Expenses | -66.67% | -100.00% | -57.14% | -57.14% | -57.14% |
| Earnings from Continuing Operations | 90.29% | 89.87% | -29.56% | -613.42% | -159.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 90.29% | 89.87% | -29.56% | -613.42% | -159.44% |
| EBIT | 79.74% | 84.53% | -36.26% | -618.65% | -160.35% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 91.43% | 90.16% | -29.03% | -630.00% | -158.33% |
| Normalized Basic EPS | 91.30% | 89.74% | -25.00% | -666.67% | -160.53% |
| EPS Diluted | -42.86% | 13.11% | -180.65% | -1,100.00% | -294.44% |
| Normalized Diluted EPS | 91.30% | 89.74% | -25.00% | -666.67% | -162.16% |
| Average Basic Shares Outstanding | 0.46% | 0.40% | 0.33% | 0.27% | 0.27% |
| Average Diluted Shares Outstanding | 0.33% | 0.53% | 0.24% | -0.04% | -0.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |